Uncategorized
Medicare Part B enrollees to get $90 payments, Trump says| STAT
President Donald Trump is promising more payments to voters just ahead of the Nov. 3 midterm elections — this time, to more than 20 million seniors, giving them $90 each to help pay for Medicare premiums. The announcement, made late Friday night by Trump on social media, comes after the president last month said about […]
NIH launching new streamlined website to ease information access
Finding information from the National Institutes of Health about human health, disease, and biomedical research is about to look a lot different. On Monday, the NIH will unveil a new version of its website that shifts attention away from individual institutes and centers and towards eight thematic hubs focused on health, research, data, clinical studies, […]
Trump’s final GLOBE rule will save Medicare much less money
WASHINGTON — The Trump administration published a final rule aimed at lowering Medicare prices for drugs administered in doctor offices. It applies to only four companies. The Global Benchmark for Efficient Drug Pricing, or GLOBE, is one of two mandatory pilot programs that are part of President Trump’s plan to get drugmakers to lower prices […]
Risk from toxic metals can persist months after wildfires, Maui study finds
Metal mixtures found in the leftover smoke, ash and debris from the deadly 2023 Maui wildfires were harmful to the lung health of people living nearby long after the burning ended, a new study says. The work shows that major wildfires, which are worsening with the planet’s warming, could have lasting effects beyond immediate exposure. […]
Three lessons from the 2001 anthrax letters
Twenty-five years ago, as the country still reeled from Sept. 11, the first of two batches of anthrax-laden envelopes were mailed from New Jersey to news media and congressional offices. All told, the letters caused 22 cases of anthrax disease, leading to five deaths; prompted considerable fear in the U.S.; and cost billions of dollars […]
FDA nominee Heidi Overton hearing: Vaccines, vapes, and China
WASHINGTON — Heidi Overton, President Trump’s nominee to lead the Food and Drug Administration, was grilled by senators on hot button topics like China, vaccines, and abortion access in her hearing before the committee that will decide whether to send her nomination for a vote of the full Senate. Throughout the two-hour hearing, Overton, a […]
FDA, NIH unveil new rules to reduce animal testing in drug development
Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter and the afternoon Pharmalot newsletter. For the second time this year, the Department of Health and Human Services announced a new set of strategies to speed a shift […]
Radiopharma companies merge after one receives surprise FDA rejection
Allison covers what hot startups are getting up to, and who’s financing them. She is also co-host of the weekly biotech podcast, “The Readout Loud.” You can reach Allison on Signal at AllisonDeAngelis.01. ITM Isotope Technologies Munich SE and Telix Pharmaceuticals, two leading companies in the burgeoning radiopharmaceuticals field, are merging in a deal worth […]
Judge blocks DHS visa cap for international researchers
A federal judge on Monday issued a preliminary injunction blocking the Trump administration from upending a long-standing policy that allows foreign students and scholars to stay in the U.S. for the duration of their training, a decision that suggests that plaintiffs opposed to the policy change are likely to ultimately succeed. The ruling halts plans […]
Breast cancer pill from AstraZeneca misses mark in pivotal study
Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. LONDON — AstraZeneca said Friday that a breast cancer pill failed in a pivotal trial testing it as a first-line therapy in advanced tumors, a result that could limit the use of the […]